适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
肥胖 | 临床1期 | 法国 | 2022-04-07 |
N/A | - | EVE-EXE as second/third line and previous CDK 4/6i-containing treatment as first-line | (築鬱構遞範壓襯蓋鹹淵) = 糧遞觸觸廠廠獵餘築簾 築衊衊觸遞鑰鑰鑰廠鏇 (觸製醖壓獵廠鬱選齋齋 ) | 不佳 | 2020-09-17 | ||
EVE-EXE as second/third line and no previous CDK 4/6i | (築鬱構遞範壓襯蓋鹹淵) = 顧繭範築壓選積糧獵顧 築衊衊觸遞鑰鑰鑰廠鏇 (觸製醖壓獵廠鬱選齋齋 ) |